The NIBSC works to support the design and establishment of a sustainable European vaccine infrastructure as part of a Horizon 2020 EC-funded project.
TRANSVAC-DS, which officially started on 01 June 2020, is being coordinated by the European Vaccine Initiative and involves a consortium of 25 partner organisations from across eleven countries.
TRANSVAC-DS builds on the successes of TRANSVAC1 and TRANSVAC2 projects (www.transvac.org), and the ultimate goal is the establishment of a truly sustainable pan-European Research Infrastructure bringing together leading European scientific expert groups with their state-of-the-art resources that will accelerate the development of safe, effective and affordable vaccines for global public health.A leaflet is available with further information.The NIBSC contributes in several work packages involving ‘gaps and needs’ analysis of the research infrastructure landscape, stakeholder engagement and establishment of a suitable business model. We are co-leading with the work focused on the identification of potential ethical issues that could arise from a future sustainable Research Infrastructure and developing guidance document to ensure compliance with regulations. Further information about TRANSVAC-DS is available here. https://www.transvac.org/transvac-ds